Cerus - 23 Year Stock Price History | CERS

Historical daily share price chart and data for Cerus since 1997 adjusted for splits. The latest closing stock price for Cerus as of February 24, 2020 is 5.03.
  • The all-time high Cerus stock closing price was 80.50 on December 28, 2000.
  • The Cerus 52-week high stock price is 6.88, which is 36.8% above the current share price.
  • The Cerus 52-week low stock price is 3.70, which is 26.4% below the current share price.
  • The average Cerus stock price for the last 52 weeks is 5.11.
Cerus Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 4.5851 4.2500 5.4100 4.0100 5.0300 19.19%
2019 5.3073 5.3400 6.8500 3.8400 4.2200 -16.77%
2018 5.9496 3.5600 7.7800 3.5600 5.0700 50.00%
2017 3.3151 4.3300 4.6100 2.0200 3.3800 -22.30%
2016 5.8151 6.2400 7.3900 4.2200 4.3500 -31.17%
2015 5.0900 6.5150 6.5900 3.8600 6.3200 1.28%
2014 4.7555 6.4800 7.9500 3.5000 6.2400 -3.26%
2013 5.0364 3.1900 6.9400 2.9500 6.4500 104.11%
2012 3.3740 2.8600 4.3200 2.7600 3.1600 12.86%
2011 2.7593 2.4800 3.5700 1.9800 2.8000 13.82%
2010 2.8919 1.8000 3.9300 1.7800 2.4600 23.62%
2009 1.4225 0.8200 2.9800 0.6200 1.9900 184.29%
2008 4.3830 6.5600 7.2400 0.5800 0.7000 -89.25%
2007 6.9439 5.6800 10.1800 5.1300 6.5100 11.09%
2006 7.9441 10.0100 14.4800 5.3100 5.8600 -42.27%
2005 5.7493 3.1000 11.3300 3.0500 10.1500 244.07%
2004 2.9397 4.5000 4.7100 1.8500 2.9500 -35.02%
2003 7.4819 21.7200 21.7200 3.4000 4.5400 -78.88%
2002 33.4212 46.7700 58.6800 11.8700 21.5000 -53.01%
2001 55.9461 69.7500 75.3500 33.6300 45.7500 -39.20%
2000 49.3281 24.8800 80.5000 24.8800 75.2500 183.96%
1999 23.9083 20.5000 31.2500 15.4400 26.5000 26.19%
1998 16.4552 22.0000 23.7500 12.0000 21.0000 -4.55%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.820B $0.075B
Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $154.651B 26.99
Medtronic (MDT) Ireland $151.838B 20.41
Stryker (SYK) United States $84.017B 27.16
Boston Scientific (BSX) United States $59.405B 26.81
Baxter (BAX) United States $47.313B 28.69
EssilorLuxottica Societe Anonyme (ESLOY) France $33.638B 0.00
Zimmer Biomet Holdings (ZBH) United States $32.373B 20.00
Lonza Group Ag (LZAGY) Switzerland $31.917B 0.00
Coloplast (CLPBY) Denmark $30.078B 46.42
Terumo (TRUMY) Japan $25.672B 0.00
ResMed (RMD) United States $25.146B 43.69
Smith & Nephew SNATS (SNN) United Kingdom $22.065B 0.00
Sunny Optical Technology (SNPTF) China $18.195B 0.00
Insulet (PODD) United States $13.125B 624.44
Bio-Rad Laboratories (BIO) United States $11.989B 56.01
Perrigo (PRGO) Ireland $8.148B 15.19
William Demant Holdings (WILYY) Denmark $7.896B 0.00
Canopy Growth (CGC) Canada $7.644B 0.00
GN STORE NORD (GNNDY) Denmark $7.537B 0.00
DiaSorin S.p.A (DSRLF) Italy $7.161B 0.00
Hill-Rom Holdings (HRC) United States $7.118B 20.47
Haemonetics (HAE) United States $5.950B 36.62
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
ICU Medical (ICUI) United States $4.460B 29.07
Envista Holdings (NVST) United States $4.366B 0.00
NuVasive (NUVA) United States $3.920B 30.31
GW Pharmaceuticals (GWPH) United Kingdom $3.883B 0.00
Neogen (NEOG) United States $3.798B 63.21
Agios Pharmaceuticals (AGIO) United States $3.639B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.493B 0.00
Quidel (QDEL) United States $3.325B 29.19
National Vision Holdings (EYE) United States $2.844B 64.20
Aurora Cannabis (ACB) Canada $1.952B 0.00
AtriCure (ATRC) United States $1.559B 0.00
TG Therapeutics (TGTX) United States $1.555B 0.00
Cardiovascular Systems (CSII) United States $1.417B 0.00
InMode (INMD) Israel $1.247B 0.00
NanoString Technologies (NSTG) United States $1.194B 0.00
Aphria (APHA) $1.105B 0.00
Phibro Animal Health (PAHC) United States $1.088B 21.52
PetIQ (PETQ) United States $0.983B 23.97
VAREX IMAGING (VREX) United States $0.966B 20.08
Quanterix (QTRX) United States $0.782B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.713B 27.31
Omeros (OMER) United States $0.697B 0.00
Lantheus Holdings (LNTH) United States $0.650B 16.25
LeMaitre Vascular (LMAT) United States $0.607B 34.52
MacroGenics (MGNX) United States $0.561B 0.00
Surmodics (SRDX) United States $0.504B 58.00
Organigram Holdings (OGI) Canada $0.438B 0.00
Owens & Minor (OMI) United States $0.437B 16.16
HEXO (HEXO) $0.401B 0.00
Zynex (ZYXI) United States $0.388B 43.93
OraSure Technologies (OSUR) United States $0.376B 46.85
Utah Medical Products (UTMD) United States $0.361B 25.64
Meridian Bioscience (VIVO) United States $0.332B 13.35
BioLife Solutions (BLFS) United States $0.320B 130.25
Female Health (VERU) United States $0.296B 0.00
Repro-Med Systems (KRMD) United States $0.286B 0.00
Bovie Medical (APYX) United States $0.260B 0.00
Cytosorbents (CTSO) United States $0.213B 0.00
Viemed Healthcare (VMD) United States $0.212B 22.36
Rockwell Medical (RMTI) United States $0.205B 0.00
Vapotherm (VAPO) United States $0.197B 0.00
United Health Products (UEEC) United States $0.185B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.172B 0.00
Liberty Health Sciences (LHSIF) Canada $0.171B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.133B 0.00
Fonar (FONR) United States $0.132B 9.58
Surface Oncology (SURF) United States $0.107B 0.00
Chimerix (CMRX) United States $0.106B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
MTech Acquisition (KERN) United States $0.080B 0.00
United-Guardian (UG) United States $0.074B 18.80
Nephros (NEPH) United States $0.071B 0.00
Chembio Diagnostics (CEMI) United States $0.069B 0.00
FSD PHARMA INC (HUGE) Canada $0.047B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
NF Energy Saving (BIMI) China $0.033B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
GUARDION HEALTH (GHSI) United States $0.023B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.015B 0.00
Senestech (SNES) United States $0.007B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00